Patent: 6,610,830
✉ Email this page to a colleague
Summary for Patent: 6,610,830
| Title: | Microbial production of mature human leukocyte interferons |
| Abstract: | Disclosed herein are methods and means of microbially producing, via recombinant DNA technology, mature human leukocyte interferons, useful in the treatment of viral and neoplastic diseases. |
| Inventor(s): | Goeddel; David V. (Burlingame, CA), Pestka; Sidney (North Caldwell, NJ) |
| Assignee: | Hoffman-La Roche Inc. (Nutley, NJ) Genentech, Inc. (South San Francisco, CA) |
| Application Number: | 06/256,204 |
| Patent Claims: | see list of patent claims |
Details for Patent 6,610,830
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Merck Sharp & Dohme Llc | INTRON A | interferon alfa-2b | For Injection | 103132 | June 04, 1986 | 6,610,830 | 2001-04-21 |
| Merck Sharp & Dohme Llc | INTRON A | interferon alfa-2b | For Injection | 103132 | 6,610,830 | 2001-04-21 | |
| Merck Sharp & Dohme Llc | INTRON A | interferon alfa-2b | Injection | 103132 | 6,610,830 | 2001-04-21 | |
| Merck Sharp & Dohme Llc | PEGINTRON | peginterferon alfa-2b | Injection | 103949 | January 19, 2001 | 6,610,830 | 2001-04-21 |
| Merck Sharp & Dohme Llc | SYLATRON | peginterferon alfa-2b | For Injection | 103949 | March 29, 2011 | 6,610,830 | 2001-04-21 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 6,610,830
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Argentina | 242833 | ⤷ Start Trial |
| Austria | 380272 | ⤷ Start Trial |
| Austria | 394207 | ⤷ Start Trial |
| Austria | 394208 | ⤷ Start Trial |
| Austria | A170285 | ⤷ Start Trial |
| Austria | A170385 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
